Oppenheimer & Co’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Sell
34,647
-200
-0.6% -$59.4K 0.12% 171
2025
Q4
$9.52M Sell
34,847
-442
-1% -$120K 0.14% 162
2025
Q3
$9.53M Buy
35,289
+453
+1% +$123K 0.12% 187
2025
Q2
$9.6M Sell
34,836
-1,455
-4% -$396K 0.13% 173
2025
Q1
$9.63M Buy
36,291
+246
+0.7% +$60.7K 0.15% 157
2024
Q4
$8.37M Buy
36,045
+70
+0.2% +$16.1K 0.12% 169
2024
Q3
$7.94M Sell
35,975
-267
-0.7% -$55.3K 0.12% 187
2024
Q2
$7.13M Buy
36,242
+525
+1% +$108K 0.11% 194
2024
Q1
$7.69M Buy
35,717
+3,529
+11% +$741K 0.13% 181
2023
Q4
$6.78M Sell
32,188
-1,006
-3% -$215K 0.12% 191
2023
Q3
$6.65M Buy
33,194
+306
+0.9% +$60.8K 0.14% 171
2023
Q2
$6.09M Buy
32,888
+3,586
+12% +$663K 0.12% 190
2023
Q1
$5.61M Buy
29,302
+696
+2% +$126K 0.12% 213
2022
Q4
$4.81M Buy
28,606
+1,952
+7% +$339K 0.11% 233
2022
Q3
$4.72M Sell
26,654
-598
-2% -$118K 0.11% 228
2022
Q2
$5.58M Sell
27,252
-175
-0.6% -$37.1K 0.12% 204
2022
Q1
$6.52M Sell
27,427
-989
-3% -$232K 0.12% 206
2021
Q4
$6.49M Buy
28,416
+53
+0.2% +$11.7K 0.11% 208
2021
Q3
$5.49M Buy
28,363
+1,951
+7% +$395K 0.1% 229
2021
Q2
$5.62M Buy
26,412
+22
+0.1% +$4.64K 0.1% 240
2021
Q1
$5.39M Sell
26,390
-4,725
-15% -$931K 0.11% 225
2020
Q4
$5.67M Sell
31,115
-798
-3% -$136K 0.12% 191
2020
Q3
$5.34M Sell
31,913
-5,098
-14% -$859K 0.13% 163
2020
Q2
$6.02M Sell
37,011
-1,637
-4% -$293K 0.16% 132
2020
Q1
$6.68M Buy
38,648
+3,509
+10% +$698K 0.2% 104
2019
Q4
$7.05M Buy
35,139
+75
+0.2% +$15.4K 0.17% 127
2019
Q3
$7.41M Sell
35,064
-1,161
-3% -$243K 0.2% 103
2019
Q2
$7.03M Sell
36,225
-8,548
-19% -$1.58M 0.19% 113
2019
Q1
$7.37M Sell
44,773
-2,392
-5% -$423K 0.2% 107
2018
Q4
$8.87M Buy
47,165
+4,829
+11% +$892K 0.28% 82
2018
Q3
$7.21M Buy
42,336
+222
+0.5% +$37.4K 0.18% 116
2018
Q2
$6.9M Buy
42,114
+56
+0.1% +$9.15K 0.19% 123
2018
Q1
$6.8M Sell
42,058
-5,175
-11% -$824K 0.17% 134
2017
Q4
$6.9M Buy
47,233
+447
+1% +$63.7K 0.18% 130
2017
Q3
$6.35M Buy
46,786
+1,240
+3% +$157K 0.17% 135
2017
Q2
$5.7M Buy
45,546
+9,687
+27% +$1.16M 0.16% 152
2017
Q1
$4.26M Sell
35,859
-5,114
-12% -$615K 0.12% 203
2016
Q4
$4.73M Buy
40,973
+2,448
+6% +$272K 0.14% 171
2016
Q3
$4.03M Sell
38,525
-2,217
-5% -$231K 0.12% 197
2016
Q2
$3.97M Sell
40,742
-838
-2% -$79.2K 0.12% 202
2016
Q1
$3.99M Buy
41,580
+2,319
+6% +$211K 0.12% 194
2015
Q4
$3.56M Buy
39,261
+7,824
+25% +$736K 0.11% 222
2015
Q3
$2.92M Buy
31,437
+1
+0% +$95 0.09% 268
2015
Q2
$2.92M Sell
31,436
-41,784
-57% -$3.9M 0.08% 291
2015
Q1
$6.93M Buy
73,220
+41,497
+131% +$3.84M 0.19% 125
2014
Q4
$2.81M Sell
31,723
-1,237
-4% -$105K 0.08% 293
2014
Q3
$2.64M Sell
32,960
-805
-2% -$60.7K 0.08% 300
2014
Q2
$2.4M Sell
33,765
-22
-0.1% -$1.55K 0.07% 323
2014
Q1
$2.5M Buy
33,787
+197
+0.6% +$14.9K 0.08% 325
2013
Q4
$2.63M Sell
33,590
-349
-1% -$27.3K 0.08% 291
2013
Q3
$2.51M Buy
33,939
+49
+0.1% +$3.61K 0.09% 281
2013
Q2
$2.57M Buy
+33,890
New +$2.22M 0.1% 253

Other funds holding CME

Oppenheimer & Co's CME Position: Q1 2026 in Review

Oppenheimer & Co reduced its CME Group (CME) stake by 0.57% in Q1 2026, selling an estimated $59.4K and leaving 34,647 shares worth $10.2M. The position accounts for 0.12% of the portfolio, ranked #171.

Oppenheimer & Co first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Oppenheimer & Co held 34,647 shares of CME Group worth $10.2M as of Q1 2026.
  • Oppenheimer & Co sold 200 CME Group shares in Q1 2026, an estimated $59.4K.
  • CME Group made up 0.12% of Oppenheimer & Co's portfolio in Q1 2026, its #171 holding.
  • Oppenheimer & Co first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.